Zambrano, Betzana
Peterson, James
Deseda, Carmen
Julien, Katie
Spiegel, Craig A.
Seyler, Clifford
Simon, Michael
Hoki, Robert
Anderson, Marc
Brabec, Brad
Áñez, Germán
Shi, Jiayuan
Pan, Judy
Hagenbach, Audrey
Von Barbier, Dalia
Varghese, Kucku
Jordanov, Emilia
Dhingra, Mandeep Singh
Article History
Received: 20 July 2022
Revised: 29 November 2022
Accepted: 3 January 2023
First Online: 10 March 2023
Change Date: 18 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41390-023-02835-4
Competing interests
: B.Z., J.S., J.Pa., A.H., D.V.B., K.V., E.J. and M.S.D. are employees of Sanofi and may hold stocks/shares. C.D., K.J. and J.Pe. received funding from Sanofi to support work for the trial. B.B., R.H., M.S., C.Se., C.Sp. and M.A. have no conflicts of interest to declare. G.Á. was an employee of Sanofi at the time this study was conducted.
: Participants aged ≥13 to <18 years of age signed an assent form and their parent or guardian signed and dated the informed consent form (ICF) before any procedure or treatment associated with the trial performed. Those ≥18 years of age signed and dated the ICF themselves.